Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer
Authors
Keywords
-
Journal
INTERNAL MEDICINE JOURNAL
Volume 44, Issue 7, Pages 676-682
Publisher
Wiley
Online
2014-04-22
DOI
10.1111/imj.12453
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
- (2013) M Stotz et al. BRITISH JOURNAL OF CANCER
- The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
- (2013) Graeme J.K. Guthrie et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
- (2012) Donald C. McMillan CANCER TREATMENT REVIEWS
- Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer
- (2012) Supachai Raungkaewmanee et al. Journal of Gynecologic Oncology
- Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment
- (2012) Takashi Motomura et al. JOURNAL OF HEPATOLOGY
- Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer
- (2012) De-shen Wang et al. MEDICAL ONCOLOGY
- Paraneoplastic Thrombocytosis in Ovarian Cancer
- (2012) Rebecca L. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
- (2011) W Chua et al. BRITISH JOURNAL OF CANCER
- An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
- (2011) M J Proctor et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) is Associated with Reduced Disease-free Survival Following Curative Resection of Pancreatic Adenocarcinoma
- (2011) G. Garcea et al. WORLD JOURNAL OF SURGERY
- Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio
- (2010) Imran Bhatti et al. AMERICAN JOURNAL OF SURGERY
- The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer
- (2010) G. Kasymjanova et al. Current Oncology
- Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
- (2009) Campbell SD Roxburgh et al. Future Oncology
- Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
- (2008) Richard A. Smith et al. AMERICAN JOURNAL OF SURGERY
- Chronic inflammation and pancreatic cancer
- (2008) Colin J. McKay et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started